ARDELYX, INC. Cost of Services, Amortization (Deprecated 2018-01-31)
ARDELYX, INC. (ARDX) reported Cost of Services, Amortization (Deprecated 2018-01-31) of $142.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfServicesAmortization · last filed 2017-11-07
- ARDELYX, INC. cost of services, amortization (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $51.00K, a 8.51% increase year-over-year.
- ARDELYX, INC. cost of services, amortization (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $45.00K, a 16.67% decline year-over-year.
- ARDELYX, INC. cost of services, amortization (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $46.00K, a 2.13% decline year-over-year.
- ARDELYX, INC. cost of services, amortization (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $46.00K.
- ARDELYX, INC. cost of services, amortization (deprecated 2018-01-31) for fiscal 2016 was $194.00K, a 81.31% increase from fiscal 2015.
- ARDELYX, INC. cost of services, amortization (deprecated 2018-01-31) for fiscal 2015 was $107.00K.
| Period end | Cost of Services, Amortization (Deprecated 2018-01-31) 3 month | Cost of Services, Amortization (Deprecated 2018-01-31) 6 month | Cost of Services, Amortization (Deprecated 2018-01-31) 9 month | Cost of Services, Amortization (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $96.00K derived: sum of 2 quarters · filed 2017-11-07 | $142.00K 10-Q · filed 2017-11-07 | $188.00K derived: sum of 4 quarters · filed 2017-11-07 |
| 2017-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $91.00K 10-Q · filed 2017-08-09 | $137.00K derived: sum of 3 quarters · filed 2017-08-09 | $184.00K derived: sum of 4 quarters · filed 2017-11-07 |
| 2017-03-31 | $46.00K 10-Q · filed 2017-05-05 | $92.00K derived: sum of 2 quarters · filed 2017-05-05 | $139.00K derived: sum of 3 quarters · filed 2017-11-07 | $193.00K derived: sum of 4 quarters · filed 2017-11-07 |
| 2016-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $93.00K derived: sum of 2 quarters · filed 2017-11-07 | $147.00K derived: sum of 3 quarters · filed 2017-11-07 | $194.00K 10-K · filed 2017-02-17 |
| 2016-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $101.00K derived: sum of 2 quarters · filed 2017-11-07 | $148.00K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $101.00K 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $47.00K 10-Q · filed 2017-05-05 | |||
| 2015-12-31 | $107.00K 10-K · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |